                         SEQUENCE LISTING

<110>  King Abdullah University of Science and Technology
       Abusamra, Dina B
       Merzaban, Jasmeen S
       Al-Amoodi, Asma
 
<120>  Compositions and Methods for Preparing CD34 neg Stem Cells for 
       Transplant

<130>  064673.020PCT

<160>  10    

<170>  PatentIn version 3.5

<210>  1
<211>  65
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  1

Leu Gly Ile Leu Asp Phe Thr Glu Gln Asp Val Ala Ser His Gln Ser 
1               5                   10                  15      


Tyr Ser Gln Lys Thr Ser Ser Cys Ala Glu Phe Lys Lys Leu Gly Ile 
            20                  25                  30          


Leu Asp Phe Thr Glu Gln Asp Val Ala Ser His Gln Ser Tyr Ser Gln 
        35                  40                  45              


Lys Thr Ser Ser Cys Ala Glu Phe Lys Asp Arg Gly Glu Gly Leu Ala 
    50                  55                  60                  


Arg 
65  


<210>  2
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  2

Phe Glu Asp Gly Gly Tyr Val Val Cys Asn Thr Arg Ser Ile Ile Leu 
1               5                   10                  15      


Ser Gly Thr Val Leu Pro Ser Ala Gln Arg 
            20                  25      


<210>  3
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  3

Phe Glu Asp Gly Gly Tyr Val Val Cys Asn Thr Arg 
1               5                   10          


<210>  4
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  4

Leu Val Ile Asn Ser Gly Asn Gly Ala Val Glu Asp Arg Ser Gln Glu 
1               5                   10                  15      


Met Val His Leu Val Asn Lys Asn Leu Gln Asn Val Asp Met Lys 
            20                  25                  30      


<210>  5
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  5

Ala Ser His Glu Glu Val Glu Gly Leu Val Glu Lys Leu Ala Asp Gly 
1               5                   10                  15      


Gly Ala Thr Asn Gln Gly Arg Ala Val Asp Thr Trp Ser Trp Gly Glu 
            20                  25                  30          


Arg 
    


<210>  6
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  6

Thr Gly Ala Leu Val Leu Ser Arg 
1               5               


<210>  7
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  7

Thr Thr Glu Gly Cys Leu Asn Pro Arg Tyr Asn Gly Gln Val Cys Gly 
1               5                   10                  15      


Gly Pro Gly Arg Ser Ser Gln Glu Leu Glu Gly Ser Cys Arg 
            20                  25                  30  


<210>  8
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  8

Ser Pro Gly Leu Thr Pro Glu Pro Arg 
1               5                   


<210>  9
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  9

Glu Met Asp Leu Gly Leu Leu Ser Pro Gln Ala Gln Val Glu Asp Ser 
1               5                   10                  15      


<210>  10
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  10

His Gly Gly Leu Ser Pro Gln Pro Ser Gln Arg 
1               5                   10      


